Cardio Diagnostics Holdings, Inc.
Support and Resistance Levels
Past performance
News About CDIO
All events for CDIO
All deals for CDIO
Financial Ratios
Financial Statements
CDIO vs Sector & Peers
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017. Website cdio.ai
Headquarters Chicago, IL, US